Kidney function may change how obesity drug works
NCT ID NCT07347808
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at how a single dose of the drug VCT220 behaves in people with moderate kidney problems compared to those with healthy kidneys. Researchers measured drug levels in the blood and checked for side effects. The goal is to find the right dose for people with kidney issues. 16 adults aged 18-75 took part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OBESITY & OVERWEIGHT are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Fiber gummies: a tasty new weapon against obesity?
- Can a diabetes drug improve joint replacement outcomes?
- Can a new pill help older adults lose weight without losing strength?
- Can one avocado a day sharpen the aging brain?
- Can a strict diet put type 2 diabetes into remission?
- Can Weight-Loss surgery alter how medications work?